EUVIMEDEUVIMED entdecken
Open Access

Development and Antibacterial Properties of 4-[4-(Anilinomethyl)-3-phenylpyrazol-1-yl]benzoic Acid Derivatives as Fatty Acid Biosynthesis Inhibitors

Subrata Roy, Hansa Raj Kc, Justin Roberts, Jared Hastings, David F Gilmore, Robert C Shields iD, Mohammad A Alam iD

Journal of Medicinal Chemistry · 2023

DOI: 10.1021/acs.jmedchem.3c00969 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Subrata Roy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Physics, College of Science and Mathematics, Arkansas State University, Jonesboro, Arkansas 72467, United States. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Microbial Sensitivity Tests, Biofilms, Pyrazoles. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, Colgate-Palmolive Company, Arkansas Biosciences Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A number of novel pyrazole derivatives have been synthesized, and several of these compounds are potent antibacterial agents with minimum inhibitory concentrations as low as 0.5 μg/mL. Human cell lines were tolerant to these lead compounds, and they showed negligible hemolytic effects at high concentrations. These bactericidal compounds are very effective against bacterial growth in both planktonic and biofilm contexts. Various techniques were applied to show the inhibition of biofilm growth and eradication of preformed biofilms by lead compounds. Potent compounds are more effective against persisters than positive controls. In vivo studies revealed that lead compounds are effective in rescuing C. elegans from bacterial infections. Several methods were applied to determine the mode of action including membrane permeability assay and SEM micrograph studies. Furthermore, CRISPRi studies led to the determination of these compounds as fatty acid biosynthesis (FAB) inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsMicrobial Sensitivity TestsBiofilmsPyrazolesCaenorhabditis elegansFatty AcidsHumansAnimalsStructure-Activity RelationshipBenzoates

Substanzen

Anti-Bacterial AgentsPyrazolesFatty AcidsBenzoates

Autor:innen und Institutionen

  • Department of Chemistry and Physics, College of Science and Mathematics, Arkansas State University, Jonesboro, Arkansas 72467, United States.
  • Department of Biological Sciences, College of Science and Mathematics, Arkansas State University, Jonesboro, Arkansas 72467, United States.

ORCID-Profile: Robert C Shields, Mohammad A Alam

Förderung

  • NIGMS NIH HHS
  • Colgate-Palmolive Company
  • Arkansas Biosciences Institute
  • National Institute of General Medical Sciences
  • National Science Foundation

Zitieren

APA

Roy, S., Kc, H. R., Roberts, J., Hastings, J., Gilmore, D. F., Shields, R. C., & Alam, M. A. (2023). Development and Antibacterial Properties of 4-[4-(Anilinomethyl)-3-phenylpyrazol-1-yl]benzoic Acid Derivatives as Fatty Acid Biosynthesis Inhibitors. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.3c00969

Vancouver

Roy S, Kc HR, Roberts J, Hastings J, Gilmore DF, Shields RC, et al. Development and Antibacterial Properties of 4-[4-(Anilinomethyl)-3-phenylpyrazol-1-yl]benzoic Acid Derivatives as Fatty Acid Biosynthesis Inhibitors. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.3c00969

BibTeX
@article{Roy2023,
  author = {Roy, Subrata and Kc, Hansa Raj and Roberts, Justin and Hastings, Jared and Gilmore, David F and Shields, Robert C and Alam, Mohammad A},
  title = {Development and Antibacterial Properties of 4-[4-(Anilinomethyl)-3-phenylpyrazol-1-yl]benzoic Acid Derivatives as Fatty Acid Biosynthesis Inhibitors},
  journal = {Journal of Medicinal Chemistry},
  year = {2023},
  doi = {10.1021/acs.jmedchem.3c00969}
}
Kostenlos starten →